600216 浙江醫藥
按盤價 
13.210 -0.400 (-2.939%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.588 | 8.090 | 11.446 | 4.549 | 5.982 |
| 總資產報酬率 ROA (%) | 2.031 | 6.264 | 8.734 | 3.408 | 4.323 |
| 投入資產回報率 ROIC (%) | 2.358 | 7.424 | 10.523 | 4.160 | 5.411 | 邊際利潤分析 |
| 銷售毛利率 (%) | 35.055 | 34.668 | 42.332 | 32.387 | 34.470 |
| 營業利潤率 (%) | 13.983 | 10.843 | 13.046 | 4.877 | 6.218 |
| 息稅前利潤/營業總收入 (%) | 15.692 | 9.895 | 12.878 | 4.437 | 5.587 |
| 淨利潤/營業總收入 (%) | 11.793 | 8.561 | 10.882 | 3.551 | 4.468 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 91.850 | 111.732 | 118.883 | 30.963 | 128.977 |
| 價值變動淨收益/利潤總額(%) | 3.442 | 0.759 | -2.442 | -3.745 | -11.500 |
| 營業外收支淨額/利潤總額(%) | 0.032 | -1.177 | -0.893 | -4.646 | -2.692 | 償債能力分析 |
| 流動比率 (X) | 3.388 | 2.956 | 2.563 | 2.260 | 2.294 |
| 速動比率 (X) | 2.537 | 2.196 | 1.733 | 1.449 | 1.485 |
| 資產負債率 (%) | 19.843 | 21.302 | 21.221 | 21.856 | 21.900 |
| 帶息債務/全部投入資本 (%) | 7.532 | 6.866 | 6.265 | 7.443 | 8.284 |
| 股東權益/帶息債務 (%) | 1,206.512 | 1,331.579 | 1,470.285 | 1,232.741 | 1,100.412 |
| 股東權益/負債合計 (%) | 399.541 | 364.582 | 363.724 | 344.798 | 340.092 |
| 利息保障倍數 (X) | 9.209 | -12.042 | -243.513 | -19.773 | -11.943 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 62.838 | 62.729 | 55.285 | 58.895 | 60.809 |
| 存貨周轉天數 (天) | 115.485 | 123.701 | 137.940 | 136.804 | 130.911 |
| 備註： | 即時報價更新時間為 25/05/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
